Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$284,911,309
New position
Shares Held
1,444,637
first reported quarter
Ownership
0.093%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $2,972,093,575 across 11 Drug Manufacturers - General names. AZN ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,409,868 | $1,077,948,133 | |
| 2 | LLY |
ELI LILLY & Co
|
506,081 | $465,478,121 | |
| 3 | ABBV |
AbbVie Inc.
|
2,065,016 | $449,120,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,517,435 | $302,822,256 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,444,637 | $284,911,309 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,017,219 | $141,769,812 | |
| 7 | PFE |
Pfizer Inc
|
3,274,513 | $91,948,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,465,433 | $88,878,511 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $284,911,309 | 1,444,637 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||